GenSci136

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GenSci136, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. [Phase 1]